<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04607070</url>
  </required_header>
  <id_info>
    <org_study_id>Crec 2020.427</org_study_id>
    <nct_id>NCT04607070</nct_id>
  </id_info>
  <brief_title>Ischemic Strokes While on NOAC - How Compliance Matters</brief_title>
  <official_title>Ischemic Strokes While on NOAC - How Compliance Matters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to depict the epidemiological trend, aetiologies, clinical&#xD;
      characteristics, treatment options of IS-NOAC in face of the rapidly increasing NOAC usage.&#xD;
      Knowledge on this ischaemic stroke entity will define clinical characteristics, identify&#xD;
      preventable causes and inform resource allocation on the evaluation modalities, reperfusion&#xD;
      strategies and forecast future burden of IS-NOAC.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data will be retrieved from the stroke registry of Prince of Wales Hospital which recorded&#xD;
      all in- and out-patients with stroke or transient ischaemic attack (TIA). All consecutive&#xD;
      adult patients with known AF who developed ischaemic stroke or TIA in 2010, 2012, 2014, 2016&#xD;
      and 2018 (i.e. 5 full yearly time-points) and categorize the patients according to their&#xD;
      anticoagulation status (elaborated below) with the inclusion and exclusion criteria stated&#xD;
      will be recruited.&#xD;
&#xD;
      All demographic data, blood results, imaging and assessment data will be retrieved from&#xD;
      electronic patient record (CMS system) and stroke registry. All-cause mortality at 1 year&#xD;
      will be verified via CMS system too.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance affects the outcomes of ischemic stroke during NOAC usage.</measure>
    <time_frame>30 Sept 2021</time_frame>
    <description>To depict epidemiological trend and aetiologies on different dosage of NOAC in stroke patients.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">870</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke, Acute</condition>
  <condition>Stroke Syndrome</condition>
  <condition>Stroke, Cardiovascular</condition>
  <condition>Atherosclerosis</condition>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Stroke patient</arm_group_label>
    <description>This is a registry-based study that will involve consecutive adult patients with known AF who developed ischaemic stroke or TIA in years 2010, 2012, 2014, 2016 and 2018.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with known AF who developed ischaemic stroke or TIA and admitted in the Prince of&#xD;
        Wales Hospital in years 2010, 2012, 2014, 2016 and 2018 will be recruited into this study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who were ethnic Chinese&#xD;
&#xD;
          2. Patients with known AF&#xD;
&#xD;
          3. Patient who suffered from ischaemic stroke&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient who are non-ethnic Chinese&#xD;
&#xD;
          2. Patient who suffered from haemorrhagic stroke&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yiu Ming Bonaventure IP, MBChB, MRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yiu Ming Bonaventure IP, MRCP</last_name>
    <phone>852-35053856</phone>
    <email>iym984@ha.org.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yiu Ming Bonaventure IP, MRCP</last_name>
      <phone>852-35053856</phone>
      <email>iym984@ha.org.hk</email>
    </contact>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2020</study_first_posted>
  <last_update_submitted>October 23, 2020</last_update_submitted>
  <last_update_submitted_qc>October 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Dr. IP Yiu Ming Bonaventure</investigator_full_name>
    <investigator_title>Specialist resident</investigator_title>
  </responsible_party>
  <keyword>stroke, NOAC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

